
The creators of a new healthcare platform called Melo, which helps clinicians and hospital staff to track patients’ behaviour whilst they recover from brain trauma, have raised £500k to address potentially adverse episodes in healthcare settings. Manchester-based Decently, which was founded in 2021 by James Burch and James Chapman who boast 20 years health and education tech experience, raised the funds from the GMC Life Sciences Fund by Praetura, which is supported by the Greater Manchester Combined Authority, Cheshire & Warrington LEP and Bruntwood SciTech, with SFC Capital participating in the round.
The funding will be used to help Decently launch Melo across the NHS and private rehabilitation care centres by enabling the company to scale its team and grow awareness of platform, which is already being piloted by three strategic northern NHS Trusts, including the Northern Care Alliance NHS Foundation Trust, Leeds Teaching Hospitals NHS Trust and Liverpool University Hospitals NHS Foundation Trust.
.
Melo works by simplifying and streamlining the data capture process and using artificial intelligence to spot trends and behaviour escalation patterns in patients suffering acquired brain injuries (ABI) and injuries caused by non-birth related incidents, such as accidental trauma or a coma. Clinicians upload patient data based on observations and are given a real-time dashboard as well as reporting tools that make sharing information between staff and departments easier, increasing safety, raising accountability and lowering costs.
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
![]() GMC Life Sciences Fund( ) | ||||
![]() Greater Manchester Combined Authority( ) | ||||
![]() SFC Capital( ) SFC Capital is a venture capital firm that focuses on investing in early-stage t... London | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK